Home Business & Finance Novo Not Discussing Further Pill Discounts, CEO Says
Business & Finance

Novo Not Discussing Further Pill Discounts, CEO Says

Key Points

Aug 5th, 2026 Novo Not Discussing Further Pill Discounts, CEO Says Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua.

Aug 5th, 2026 Novo Not Discussing Further Pill Discounts, CEO Says Novo Nordisk A/S Chief Executive Officer Mike Doustdar talks about the company's performance as its popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype. "We are not right now discussing further discounts," Doustdar tells Bloomberg's Francine Lacqua.
Novo Nordisk (PERSON) Mike Doustdar (PERSON) Wegovy (ORG) Doustdar (PERSON) Bloomberg (PERSON) Francine Lacqua (PERSON)
Originally published by Bloomberg Markets Read original →